On Tuesday BioCryst Pharmaceuticals stock price gained impressive 9.21%
(Updated on Dec 07, 2021)
Hold candidate since 2021-12-07 PDF
The BioCryst Pharmaceuticals stock price gained 9.21% on the last trading day (Tuesday, 7th Dec 2021), rising from $11.18 to $12.21. During the day the stock fluctuated 9.78% from a day low at $11.35 to a day high of $12.46. The price has fallen in 7 of the last 10 days and is down by -1.93% for this period. Volume fell on the last day by -712 thousand shares and in total, 3 million shares were bought and sold for approximately $38.01 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -22.50% during the next 3 months and, with a 90% probability hold a price between $8.62 and $10.64 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, December 06, 2021, and so far it has risen 9.21%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioCryst Pharmaceuticals stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $13.03. On a fall, the stock will find some support from the short-term average at $11.78. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.
Support, Risk & Stop-loss
BioCryst Pharmaceuticals finds support from accumulated volume at $11.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.11 between high and low, or 9.78%. For the last week, the stock has had a daily average volatility of 8.39%.
Our recommended stop-loss: $11.79 (-3.48%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 days ago.)
Is BioCryst Pharmaceuticals stock A Buy?
BioCryst Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: 0.130
Predicted Opening Price for BioCryst Pharmaceuticals of Wednesday, December 8, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price December 8, 2021||Current price|
Remember To Visit Our YouTube Channel
On Nov 04, 2021 "Royal Bank of Canada" gave "$16.00 - $14.00" rating for BCRX. The price target was changed from $11.93 to 3.8%.
BCRX Insider Trading
|Nov 30, 2021||Buy||414||Aselage Steve||Common Stock|
|Nov 30, 2021||Buy||829||Heggie Theresa||Common Stock|
|Nov 30, 2021||Buy||829||Levin Alan G||Common Stock|
|Nov 30, 2021||Buy||1 554||Ingram Robert Alexander||Common Stock|
|Nov 24, 2021||Buy||7 500||Milano Vincent||Common Stock|
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.